Veronica Weterings
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Veronica Weterings has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Jan Kluytmans
Department of Infection Control, Amphia Hospital, Breda, the Netherlands
7 shared publications- Jean-Luc Murk
Microvida, Laboratory of Medical Microbiology, Amphia Hospital, Breda, The Netherlands
4 shared publications Wouter van Den Bijllaardt
Microvida, Laboratory of Medical Microbiology, Amphia Hospital, Breda, The Netherlands
4 shared publicationsJacobien Veenemans
Department of Infection Control, Admiraal De Ruyter Hospital, P.O. Box 15, 4460 AA, Goes, The Netherlands
3 shared publications- Jan A. J. W. Kluytmans
Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands
3 shared publications Andreas Voss
Department of Medical Microbiology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB, Nijmegen, the Netherlands
2 shared publications
Latest Publications
- Open Access
- 25 June 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (6) , e0334734
Regional VRE surveillance using routine centralised, multicentre whole genome sequencing
Objective: Whole genome sequencing (WGS) is increasingly used to support infection prevention and control. However, its application for routine regional surveillance of vancomycin-resistant Enterococcus faecium (VREfm) across multiple healthcare facilities is still evolving. This study describes the implementation of routine centralised multicenter WGS surveillance of VREfm and explores its utility for detecting clusters and investigating transmission within and between healthcare institutions in a regional healthcare network. Methods: VREfm isolates identified from patient samples (clinical and screening) in five different hospitals in the Netherlands during a one-year period were whole genome sequenced and typed using core genome multilocus sequence typing (cgMLST). Sequence data were correlated with admission data of the year prior to the first positive VREfm culture of the respective patients. By combining epidemiological and sequence data within and between hospital transmission events were identified. Results: 57 VREfm isolates were detected during the study period. 38/57 (66.7%) isolates clustered with at least one other isolate. Based on our definitions, intrahospital transmission could be demonstrated in 37 of 38 cases and interhospital transmission in 3 of 38 cases. Using this approach, a multicenter outbreak and two local outbreaks were detected. Conclusions: Routine whole genome sequencing of VREfm is a powerful tool for detecting, tracing and delineating outbreaks. When integrated into a centralised surveillance system spanning collaborative healthcare networks, it becomes an essential tool for unraveling the complex transmission dynamics of VRE within and between hospitals, ultimately strengthening infection control strategies.
- 25 June 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (6) , e0334734
Open AccessRegional VRE surveillance using routine centralised, multicentre whole genome sequencing
Objective: Whole genome sequencing (WGS) is increasingly used to support infection prevention and control. However, its application for routine regional surveillance of vancomycin-resistant Enterococcus faecium (VREfm) across multiple healthcare facilities is still evolving. This study describes the implementation of routine centralised multicenter WGS surveillance of VREfm and explores its utility for detecting clusters and investigating transmission within and between healthcare institutions in a regional healthcare network. Methods: VREfm isolates identified from patient samples (clinical and screening) in five different hospitals in the Netherlands during a one-year period were whole genome sequenced and typed using core genome multilocus sequence typing (cgMLST). Sequence data were correlated with admission data of the year prior to the first positive VREfm culture of the respective patients. By combining epidemiological and sequence data within and between hospital transmission events were identified. Results: 57 VREfm isolates were detected during the study period. 38/57 (66.7%) isolates clustered with at least one other isolate. Based on our definitions, intrahospital transmission could be demonstrated in 37 of 38 cases and interhospital transmission in 3 of 38 cases. Using this approach, a multicenter outbreak and two local outbreaks were detected. Conclusions: Routine whole genome sequencing of VREfm is a powerful tool for detecting, tracing and delineating outbreaks. When integrated into a centralised surveillance system spanning collaborative healthcare networks, it becomes an essential tool for unraveling the complex transmission dynamics of VRE within and between hospitals, ultimately strengthening infection control strategies.
- Open Access
Surveillance of interhospital VRE transmission using routine centralised, multicentre whole genome sequencing
Objective: Whole genome sequencing (WGS) is increasingly being used to guide infection prevention and control measures. However, the value of regional prospective WGS surveillance for vancomycin-resistant Enterococcus faecium (VREfm) remains uncertain. The objective of this study is to investigate the value of routine centralised multicentre WGS in regional outbreak detection and analysis of transmission of VREfm within and between healthcare facilities. Methods: VREfm isolates identified from patient samples in five different hospitals in the Netherlands during a one-year period were whole genome sequenced and typed using core genome multilocus sequence typing (cgMLST). Sequence data were correlated with admission data of the year prior to the first positive VREfm culture of the respective patients. By combining epidemiological and sequence data within and between hospital transmission events were identified. Results: 57 VREfm isolates were detected during the study period. 38/57 (66.7%) isolates clustered with at least one other isolate. Based on our definitions, intrahospital transmission could be demonstrated in 37 of 38 cases and interhospital transmission in 3 of 38 cases. Using this approach, a multicenter outbreak and two local outbreaks were detected. Conclusions: Routine whole genome sequencing of VRE is a powerful tool for detecting, tracing and delineating outbreaks. When integrated into a centralised surveillance system spanning collaborative healthcare networks, it becomes an essential tool for unravelling the complex transmission dynamics of VRE within and between hospitals, ultimately strengthening infection control strategies.
Open AccessSurveillance of interhospital VRE transmission using routine centralised, multicentre whole genome sequencing
Objective: Whole genome sequencing (WGS) is increasingly being used to guide infection prevention and control measures. However, the value of regional prospective WGS surveillance for vancomycin-resistant Enterococcus faecium (VREfm) remains uncertain. The objective of this study is to investigate the value of routine centralised multicentre WGS in regional outbreak detection and analysis of transmission of VREfm within and between healthcare facilities. Methods: VREfm isolates identified from patient samples in five different hospitals in the Netherlands during a one-year period were whole genome sequenced and typed using core genome multilocus sequence typing (cgMLST). Sequence data were correlated with admission data of the year prior to the first positive VREfm culture of the respective patients. By combining epidemiological and sequence data within and between hospital transmission events were identified. Results: 57 VREfm isolates were detected during the study period. 38/57 (66.7%) isolates clustered with at least one other isolate. Based on our definitions, intrahospital transmission could be demonstrated in 37 of 38 cases and interhospital transmission in 3 of 38 cases. Using this approach, a multicenter outbreak and two local outbreaks were detected. Conclusions: Routine whole genome sequencing of VRE is a powerful tool for detecting, tracing and delineating outbreaks. When integrated into a centralised surveillance system spanning collaborative healthcare networks, it becomes an essential tool for unravelling the complex transmission dynamics of VRE within and between hospitals, ultimately strengthening infection control strategies.
- Open Access
- 29 July 2025
- Published by Microbiology Society in Microbial Genomics
- Vol. 11 (7) , 001458
Molecular characterization and prevalence of plasmids co-harbouring mcr and ESBL genes
Multidrug-resistant Enterobacterales isolates carrying extended-spectrum beta-lactamases (ESBLs) and mobile colistin resistance (mcr) genes pose a significant healthcare threat as they can lead to difficult-to-treat infections. This study investigates the prevalence of isolates co-harbouring ESBL and mcr genes and characterizes the plasmids co-harbouring those genes. ESBL-producing Enterobacterales (ESBL-E) isolates identified during point prevalence surveys (PPS) in a Dutch hospital were screened for mcr genes. Plasmids co-harbouring mcr and ESBL genes were identified using long- and short-read sequencing data, while detecting resistance and replicon genes using AMRFinderPlus and PlasmidFinder. The plasmid database PLSDB was searched for plasmids containing the same mcr and ESBL gene(s), and SNP and DCJ-Indel distance analyses were conducted to examine plasmid diversity. The most recent common ancestor (MRCA) was inferred through timed phylogeny analyses in BEAST, and putative composite transposons containing the mcr or ESBL genes were identified. Among 188 screened ESBL-E, 11 harboured mcr genes: 9 with mcr-9 and 2 with mcr-9 and mcr-4.3. All plasmids containing mcr and ESBL genes were IncHI plasmids harbouring mcr-9, bla CTX-M-9 and/or bla SHV-12. The plasmid database search resulted in 128 similar plasmids. SNP analysis showed ≤10 SNPs among the PPS study plasmids and up to 924 SNPs among all plasmids. Structural relatedness and phylogenetic analyses revealed clustering of the PPS study plasmids but no additional taxonomical or geographical clustering. The MRCA of the PPS study plasmids likely emerged between 1986 and 2008. Finally, composite transposon analysis indicated that matching complete insertion sequences rarely flanked mcr-9 genes, whereas bla CTX-M-9 and bla SHV-12 frequently were. The prevalence of mcr genes among ESBL-E in this study is 5.9%, with mcr-9 being the most prevalent. Limited plasmid diversity suggests a single introduction event followed by regional and global dissemination across related bacterial species. Persistent ESBL gene mobility suggests a more recent introduction of these genes compared to the mcr-9 genes.
- 29 July 2025
- Published by Microbiology Society in Microbial Genomics
- Vol. 11 (7) , 001458
Open AccessMolecular characterization and prevalence of plasmids co-harbouring mcr and ESBL genes
Multidrug-resistant Enterobacterales isolates carrying extended-spectrum beta-lactamases (ESBLs) and mobile colistin resistance (mcr) genes pose a significant healthcare threat as they can lead to difficult-to-treat infections. This study investigates the prevalence of isolates co-harbouring ESBL and mcr genes and characterizes the plasmids co-harbouring those genes. ESBL-producing Enterobacterales (ESBL-E) isolates identified during point prevalence surveys (PPS) in a Dutch hospital were screened for mcr genes. Plasmids co-harbouring mcr and ESBL genes were identified using long- and short-read sequencing data, while detecting resistance and replicon genes using AMRFinderPlus and PlasmidFinder. The plasmid database PLSDB was searched for plasmids containing the same mcr and ESBL gene(s), and SNP and DCJ-Indel distance analyses were conducted to examine plasmid diversity. The most recent common ancestor (MRCA) was inferred through timed phylogeny analyses in BEAST, and putative composite transposons containing the mcr or ESBL genes were identified. Among 188 screened ESBL-E, 11 harboured mcr genes: 9 with mcr-9 and 2 with mcr-9 and mcr-4.3. All plasmids containing mcr and ESBL genes were IncHI plasmids harbouring mcr-9, bla CTX-M-9 and/or bla SHV-12. The plasmid database search resulted in 128 similar plasmids. SNP analysis showed ≤10 SNPs among the PPS study plasmids and up to 924 SNPs among all plasmids. Structural relatedness and phylogenetic analyses revealed clustering of the PPS study plasmids but no additional taxonomical or geographical clustering. The MRCA of the PPS study plasmids likely emerged between 1986 and 2008. Finally, composite transposon analysis indicated that matching complete insertion sequences rarely flanked mcr-9 genes, whereas bla CTX-M-9 and bla SHV-12 frequently were. The prevalence of mcr genes among ESBL-E in this study is 5.9%, with mcr-9 being the most prevalent. Limited plasmid diversity suggests a single introduction event followed by regional and global dissemination across related bacterial species. Persistent ESBL gene mobility suggests a more recent introduction of these genes compared to the mcr-9 genes.
- Open Access
SARS-CoV-2 Alpha-Variant Outbreak Amongst a Partially Vaccinated Long-Term Care Facility Population in The Netherlands—Phylogenetic Analysis and Infection Control Observations
Despite extensive vaccination and booster programs, SARS-CoV-2 outbreaks in long-term care facilities (LTCF) continue to occur. We retrospectively describe a SARS-CoV-2 outbreak amongst a partially vaccinated LTCF population in The Netherlands which occurred in March 2021. The facility comprised three floors functioning as separate wards. Nasopharyngeal swabs for SARS-CoV-2 qRT-PCR were obtained from residents and staff presenting with COVID-19-like symptoms and from all residents and staff during two point prevalence screenings (PPS). Samples meeting technical criteria were included for phylogenetic analysis. Positive SARS-CoV-2 qRT-PCR were obtained from 11 (18%) of 61 residents and 8 (7%) of 110 staff members between March 8 and March 25. Seven (37%) cases and five (63%) vaccinated cases were diagnosed through PPS. Cases were found on all wards. Phylogenetic analysis (n = 11) showed a maximum difference of four nucleotides between sequences on the outer branches of the tree, but identified two identical sequences on the root differing maximum two nucleotides from all other sequences, suggesting all did belong to the same cluster. Our results imply that PPS is useful in containing SARS-CoV-2 outbreaks amongst (vaccinated) LTCF populations, as an entire LTCF might behave as a single epidemiological unit and it is preferable to maximize the number of samples included for phylogenetic analysis.
Open AccessSARS-CoV-2 Alpha-Variant Outbreak Amongst a Partially Vaccinated Long-Term Care Facility Population in The Netherlands—Phylogenetic Analysis and Infection Control Observations
Despite extensive vaccination and booster programs, SARS-CoV-2 outbreaks in long-term care facilities (LTCF) continue to occur. We retrospectively describe a SARS-CoV-2 outbreak amongst a partially vaccinated LTCF population in The Netherlands which occurred in March 2021. The facility comprised three floors functioning as separate wards. Nasopharyngeal swabs for SARS-CoV-2 qRT-PCR were obtained from residents and staff presenting with COVID-19-like symptoms and from all residents and staff during two point prevalence screenings (PPS). Samples meeting technical criteria were included for phylogenetic analysis. Positive SARS-CoV-2 qRT-PCR were obtained from 11 (18%) of 61 residents and 8 (7%) of 110 staff members between March 8 and March 25. Seven (37%) cases and five (63%) vaccinated cases were diagnosed through PPS. Cases were found on all wards. Phylogenetic analysis (n = 11) showed a maximum difference of four nucleotides between sequences on the outer branches of the tree, but identified two identical sequences on the root differing maximum two nucleotides from all other sequences, suggesting all did belong to the same cluster. Our results imply that PPS is useful in containing SARS-CoV-2 outbreaks amongst (vaccinated) LTCF populations, as an entire LTCF might behave as a single epidemiological unit and it is preferable to maximize the number of samples included for phylogenetic analysis.
- Open Access
- 15 July 2022
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 11 (1) , 1-9
Duration of rectal colonization with extended-spectrum beta-lactamase-producing Escherichia coli: results of an open, dynamic cohort study in Dutch nursing home residents (2013–2019)
Background: In 2016, a study in a Dutch nursing home showed prolonged colonization duration of extended-spectrum β-lactamase-producing (ESBL)-ST131 compared to ESBL-non-ST131. In this study, we assessed the duration of rectal ESBL-producing E. coli (ESBL-EC) colonization in residents in the same nursing home for an extended period of six years. We aimed to estimate the influence of a possible bias when follow up is started during an outbreak. Methods: Between 2013 and 2019, repetitive point prevalence surveys were performed by culturing rectal or faecal swabs from all residents. Kaplan–Meier survival analysis was performed to calculate the median time to clearance of ESBL-EC with a log-rank analysis to test for differences between ESBL-ST131 and ESBL-non-ST131. Results: The study showed a median time to clearance of 13.0 months (95% CI 0.0–27.9) for ESBL-ST131 compared to 11.2 months (95% CI 4.8–17.6) for ESBL-non-ST131 (p = 0.044). In the subgroup analysis of residents who were ESBL-EC positive in their first survey, the median time to clearance for ST131 was 59.7 months (95% CI 23.7–95.6) compared to 16.2 months (95% CI 2.1–30.4) for ESBL-non-ST131 (p = 0.036). In the subgroup analysis of residents who acquired ESBL-EC, the median time to clearance for ST131 was 7.2 months (95% CI 2.1–12.2) compared to 7.9 months (95% CI 0.0–18.3) for ESBL-non-ST131 (p = 0.718). The median time to clearance in the ESBL-ST131 group was significantly longer in residents who were ESBL-ST131 colonised upon entering the study than in residents who acquired ESBL-ST131 during the study (p = 0.001). Conclusion: A prolonged colonization with ESBL-ST131 was only found in the subgroup who was ESBL-EC positive upon entering the study. The prolonged duration with ESBL-ST131 in the previous study was probably biased by factors that occured during (the start of) the outbreak.
- 15 July 2022
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 11 (1) , 1-9
Open AccessDuration of rectal colonization with extended-spectrum beta-lactamase-producing Escherichia coli: results of an open, dynamic cohort study in Dutch nursing home residents (2013–2019)
Background: In 2016, a study in a Dutch nursing home showed prolonged colonization duration of extended-spectrum β-lactamase-producing (ESBL)-ST131 compared to ESBL-non-ST131. In this study, we assessed the duration of rectal ESBL-producing E. coli (ESBL-EC) colonization in residents in the same nursing home for an extended period of six years. We aimed to estimate the influence of a possible bias when follow up is started during an outbreak. Methods: Between 2013 and 2019, repetitive point prevalence surveys were performed by culturing rectal or faecal swabs from all residents. Kaplan–Meier survival analysis was performed to calculate the median time to clearance of ESBL-EC with a log-rank analysis to test for differences between ESBL-ST131 and ESBL-non-ST131. Results: The study showed a median time to clearance of 13.0 months (95% CI 0.0–27.9) for ESBL-ST131 compared to 11.2 months (95% CI 4.8–17.6) for ESBL-non-ST131 (p = 0.044). In the subgroup analysis of residents who were ESBL-EC positive in their first survey, the median time to clearance for ST131 was 59.7 months (95% CI 23.7–95.6) compared to 16.2 months (95% CI 2.1–30.4) for ESBL-non-ST131 (p = 0.036). In the subgroup analysis of residents who acquired ESBL-EC, the median time to clearance for ST131 was 7.2 months (95% CI 2.1–12.2) compared to 7.9 months (95% CI 0.0–18.3) for ESBL-non-ST131 (p = 0.718). The median time to clearance in the ESBL-ST131 group was significantly longer in residents who were ESBL-ST131 colonised upon entering the study than in residents who acquired ESBL-ST131 during the study (p = 0.001). Conclusion: A prolonged colonization with ESBL-ST131 was only found in the subgroup who was ESBL-EC positive upon entering the study. The prolonged duration with ESBL-ST131 in the previous study was probably biased by factors that occured during (the start of) the outbreak.
- Open Access
- 18 February 2021
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 10 (1) , 1-10
Management of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in a Dutch general hospital, 2014–2017: successful control using a restrictive screening strategy
Background: The emergence of vancomycin resistant enterococci poses a major problem in healthcare settings. Here we describe a hospital-wide outbreak of vancomycin-resistant Enterococcus faecium in a general hospital in The Netherlands in the period December 2014–February 2017. Due to late detection of the outbreak, a large cohort of approximately 25,000 (discharged) patients was classified as ‘VRE suspected’. Hereupon a mitigated screening and isolation policy, as compared with the national guideline, was implemented to control the outbreak. Methods: After the outbreak was identified, a screening policy consisting of a single rectal swab culture (with enrichment broth) to discontinue isolation and removing ‘VRE suspected’ label in the electronic patient files for readmitted VRE suspected patients, was implemented. In addition to the on admission screening, periodic hospital-wide point prevalence screening, measures to improve compliance with standard infection control precautions and enhanced environmental cleaning were implemented to control the outbreak. Results: Between September 2014 and February 2017, 140 patients were identified to be colonised by vanA mediated vancomycin-resistant Enterococcus faecium (VREfm). Two of these patients developed bacteraemia. AFLP typing showed that the outbreak was caused by a single clone. Extensive environmental contamination was found in multiple wards. Within nine months after the detection of the outbreak no new VRE cases were detected. Conclusion: We implemented a control strategy based on targeted screening and isolation in combination with implementation of general precautions and environmental cleaning. The strategy was less stringent than the Dutch national guideline for VRE control. This strategy successfully controlled the outbreak, while it was associated with a reduction in the number of isolation days and the number of cultures taken.
- 18 February 2021
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 10 (1) , 1-10
Open AccessManagement of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in a Dutch general hospital, 2014–2017: successful control using a restrictive screening strategy
Background: The emergence of vancomycin resistant enterococci poses a major problem in healthcare settings. Here we describe a hospital-wide outbreak of vancomycin-resistant Enterococcus faecium in a general hospital in The Netherlands in the period December 2014–February 2017. Due to late detection of the outbreak, a large cohort of approximately 25,000 (discharged) patients was classified as ‘VRE suspected’. Hereupon a mitigated screening and isolation policy, as compared with the national guideline, was implemented to control the outbreak. Methods: After the outbreak was identified, a screening policy consisting of a single rectal swab culture (with enrichment broth) to discontinue isolation and removing ‘VRE suspected’ label in the electronic patient files for readmitted VRE suspected patients, was implemented. In addition to the on admission screening, periodic hospital-wide point prevalence screening, measures to improve compliance with standard infection control precautions and enhanced environmental cleaning were implemented to control the outbreak. Results: Between September 2014 and February 2017, 140 patients were identified to be colonised by vanA mediated vancomycin-resistant Enterococcus faecium (VREfm). Two of these patients developed bacteraemia. AFLP typing showed that the outbreak was caused by a single clone. Extensive environmental contamination was found in multiple wards. Within nine months after the detection of the outbreak no new VRE cases were detected. Conclusion: We implemented a control strategy based on targeted screening and isolation in combination with implementation of general precautions and environmental cleaning. The strategy was less stringent than the Dutch national guideline for VRE control. This strategy successfully controlled the outbreak, while it was associated with a reduction in the number of isolation days and the number of cultures taken.
- Open Access
- 15 January 2021
- Published by Springer Nature in Research Square
Management of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in a Dutch general hospital, 2014-2017: successful control using a restrictive screening strategy
BackgroundThe emergence of vancomycin resistant enterococci poses a major problem in healthcare settings. Here we describe a hospital-wide outbreak of vancomycin-resistant Enterococcus faecium in a general hospital in The Netherlands in the period December 2014 – February 2017. Due to late detection of the outbreak, a large cohort of approximately 25,000 (discharged) patients was classified as ‘VRE suspected’. Hereupon a mitigated screening and isolation policy, as compared with the national guideline, was implemented to control the outbreak. MethodsAfter the outbreak was identified, a screening policy consisting of a single rectal swab culture (with enrichment broth) to discontinue isolation and removing ‘VRE suspected’ label in the electronic patient files for readmitted VRE suspected patients, was implemented. In addition to the on admission screening, periodic hospital-wide point prevalence screening, measures to improve compliance with standard infection control precautions and enhanced environmental cleaning were implemented to control the outbreak.ResultsBetween September 2014 and February 2017, 140 patients were identified to be colonised by vanA mediated vancomycin-resistant Enterococcus faecium (VREfm). Two of these patients developed bacteraemia. AFLP typing showed that the outbreak was caused by a single clone. Extensive environmental contamination was found in multiple wards. Within nine months after the detection of the outbreak no new VRE cases were detected.ConclusionWe implemented a control strategy based on targeted screening and isolation in combination with implementation of general precautions and environmental cleaning. The strategy was less stringent than the Dutch national guideline for VRE control. This strategy successfully controlled the outbreak, while it was associated with a reduction in the number of isolation days and the number of cultures taken.
- 15 January 2021
- Published by Springer Nature in Research Square
Open AccessManagement of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in a Dutch general hospital, 2014-2017: successful control using a restrictive screening strategy
BackgroundThe emergence of vancomycin resistant enterococci poses a major problem in healthcare settings. Here we describe a hospital-wide outbreak of vancomycin-resistant Enterococcus faecium in a general hospital in The Netherlands in the period December 2014 – February 2017. Due to late detection of the outbreak, a large cohort of approximately 25,000 (discharged) patients was classified as ‘VRE suspected’. Hereupon a mitigated screening and isolation policy, as compared with the national guideline, was implemented to control the outbreak. MethodsAfter the outbreak was identified, a screening policy consisting of a single rectal swab culture (with enrichment broth) to discontinue isolation and removing ‘VRE suspected’ label in the electronic patient files for readmitted VRE suspected patients, was implemented. In addition to the on admission screening, periodic hospital-wide point prevalence screening, measures to improve compliance with standard infection control precautions and enhanced environmental cleaning were implemented to control the outbreak.ResultsBetween September 2014 and February 2017, 140 patients were identified to be colonised by vanA mediated vancomycin-resistant Enterococcus faecium (VREfm). Two of these patients developed bacteraemia. AFLP typing showed that the outbreak was caused by a single clone. Extensive environmental contamination was found in multiple wards. Within nine months after the detection of the outbreak no new VRE cases were detected.ConclusionWe implemented a control strategy based on targeted screening and isolation in combination with implementation of general precautions and environmental cleaning. The strategy was less stringent than the Dutch national guideline for VRE control. This strategy successfully controlled the outbreak, while it was associated with a reduction in the number of isolation days and the number of cultures taken.
- Open Access
- 31 December 2020
- Published by Springer Nature in Research Square
Duration of Colonisation With Extended-spectrum Beta-lactamase-producing Escherichia Coli: Results of an Open Cohort Study With Dutch Nursing Home Residents (2013 – 2019)
Background Escherichia coli sequence type ST131 is a recently emerged worldwide pandemic clonal group. Antibiotic resistance, virulence factors or colonisation fitness are mentioned among other as possible factors contributing to the worldwide success. In this study, we assessed the duration of rectal ESBL- producing E. coli colonisation in the residents, and compare duration of colonisation for ESBL-ST131 versus ESBL-non-ST131.MethodsRectal or faecal samples were obtained from residents of nursing home A between 2013 and 2019 and nursing home B between 2017 and 2019, with repeated point prevalence surveys at intervals of three to six months. Extended-spectrum β-lactamase (ESBL)-producing strains of E. coli were identified on selective culture and selective enrichment broth, and examined by antimicrobial susceptibility testing. In nursing home A multilocus sequence typing (MLST) and cluster analyse was performed by respectively O25:ST131-specific PCR and amplified fragment length polymorphism (AFLP). In nursing home B whole genome sequencing data were used to determine MLST and to perform a cluster analyse. Kaplan Meier survival analysis was performed to calculate the median time of rectal colonisation of ESBL-EC with a Log-Rank analysis to test for differences between ESBL-ST131 and ESBL-non-ST131.ResultsA total of 144 residents were included: 84 residents (58%) with ESBL-ST131 rectal colonisation and 60 residents (42%) with ESBL-non-ST131 rectal colonisation. Survival analysis showed a median colonisation length of 13 months for ESBL-ST131 (95%CI: 7,2 – 18,7) versus 8,3 months (95%CI: 2,8 – 13,8) for ESBL-non-ST131 (p = 0,028). Remarkably, in the subgroup ST131 the median colonisation length was significantly longer in female than in males: 25,7 months versus 8,1 months (p = 0,013).ConclusionHere we found a prolonged colonisation duration of ESBL-ST131 compared to ESBL-non-ST131 in residents of Dutch nursing homes. Prolonged colonisation duration complicates the controlling and ending an ESBL-ST131 outbreak, especially in long stay settings such as nursing homes.
- 31 December 2020
- Published by Springer Nature in Research Square
Open AccessDuration of Colonisation With Extended-spectrum Beta-lactamase-producing Escherichia Coli: Results of an Open Cohort Study With Dutch Nursing Home Residents (2013 – 2019)
Background Escherichia coli sequence type ST131 is a recently emerged worldwide pandemic clonal group. Antibiotic resistance, virulence factors or colonisation fitness are mentioned among other as possible factors contributing to the worldwide success. In this study, we assessed the duration of rectal ESBL- producing E. coli colonisation in the residents, and compare duration of colonisation for ESBL-ST131 versus ESBL-non-ST131.MethodsRectal or faecal samples were obtained from residents of nursing home A between 2013 and 2019 and nursing home B between 2017 and 2019, with repeated point prevalence surveys at intervals of three to six months. Extended-spectrum β-lactamase (ESBL)-producing strains of E. coli were identified on selective culture and selective enrichment broth, and examined by antimicrobial susceptibility testing. In nursing home A multilocus sequence typing (MLST) and cluster analyse was performed by respectively O25:ST131-specific PCR and amplified fragment length polymorphism (AFLP). In nursing home B whole genome sequencing data were used to determine MLST and to perform a cluster analyse. Kaplan Meier survival analysis was performed to calculate the median time of rectal colonisation of ESBL-EC with a Log-Rank analysis to test for differences between ESBL-ST131 and ESBL-non-ST131.ResultsA total of 144 residents were included: 84 residents (58%) with ESBL-ST131 rectal colonisation and 60 residents (42%) with ESBL-non-ST131 rectal colonisation. Survival analysis showed a median colonisation length of 13 months for ESBL-ST131 (95%CI: 7,2 – 18,7) versus 8,3 months (95%CI: 2,8 – 13,8) for ESBL-non-ST131 (p = 0,028). Remarkably, in the subgroup ST131 the median colonisation length was significantly longer in female than in males: 25,7 months versus 8,1 months (p = 0,013).ConclusionHere we found a prolonged colonisation duration of ESBL-ST131 compared to ESBL-non-ST131 in residents of Dutch nursing homes. Prolonged colonisation duration complicates the controlling and ending an ESBL-ST131 outbreak, especially in long stay settings such as nursing homes.
- Open Access
- 9 June 2020
- Published by Springer Nature in Research Square
Evaluation of the first experience with COVID-19: An observational study on the screening policy among employees and patients of a Dutch teaching hospital
BackgroundIn the beginning of March 2020, the Amphia hospital in Breda was one of the first hospitals in the Netherlands that received patients with COVID-19. Within ten days after the first COVID-19 positive patient, the number of (suspected) COVID-19 cases among patients and employees increased rapidly and thus the number of requests for SARS-CoV-2 PCR tests. From mid-March, we changed to a non-test-based strategy for employees whereby a work ban was implemented, based on the presence or absence of respiratory symptoms without the use of a diagnostic test. The objective of our study was to evaluate the safety of the non-test-based strategy. MethodsThe study period was March 1 to May 22, 2020. For all patients in whom the SARS-CoV-2 PCR test was positive > 2 days after admission, the medical record was reviewed by infection control staff for (respiratory) symptoms, laboratory results and lung CT/X-ray images to assess possible hospital-onset COVID-19. For employees, the number of sick reports per week were extracted from the department of Human Resources. Reason for reporting sick was not registered. ResultsTen of the 374 patients (2.7%) developed symptoms suspected for COVID-19 ≥3 days after admission and were tested positive for SARS-CoV-2, of which nosocomial transmission is the most likely cause in three patients. In the period in which the employees were still actively tested for SARS-CoV-2, there was a temporary increase in the number of sick reports (week 10-11). After this two-week period, the number of sick reports decreased rapidly. The total number of sick reports in the first 20 weeks of 2020 is comparable or lower than the total number of sick reports in the same period in previous years.ConclusionWith this non-test-based strategy for employees combined with a restriction of visitors to the patients and strict isolation of COVID-19 (suspected) patients, there was no excessive absenteeism of work due to illness and there were only few patients with indications of COVID-19 acquisition in the hospital.
- 9 June 2020
- Published by Springer Nature in Research Square
Open AccessEvaluation of the first experience with COVID-19: An observational study on the screening policy among employees and patients of a Dutch teaching hospital
BackgroundIn the beginning of March 2020, the Amphia hospital in Breda was one of the first hospitals in the Netherlands that received patients with COVID-19. Within ten days after the first COVID-19 positive patient, the number of (suspected) COVID-19 cases among patients and employees increased rapidly and thus the number of requests for SARS-CoV-2 PCR tests. From mid-March, we changed to a non-test-based strategy for employees whereby a work ban was implemented, based on the presence or absence of respiratory symptoms without the use of a diagnostic test. The objective of our study was to evaluate the safety of the non-test-based strategy. MethodsThe study period was March 1 to May 22, 2020. For all patients in whom the SARS-CoV-2 PCR test was positive > 2 days after admission, the medical record was reviewed by infection control staff for (respiratory) symptoms, laboratory results and lung CT/X-ray images to assess possible hospital-onset COVID-19. For employees, the number of sick reports per week were extracted from the department of Human Resources. Reason for reporting sick was not registered. ResultsTen of the 374 patients (2.7%) developed symptoms suspected for COVID-19 ≥3 days after admission and were tested positive for SARS-CoV-2, of which nosocomial transmission is the most likely cause in three patients. In the period in which the employees were still actively tested for SARS-CoV-2, there was a temporary increase in the number of sick reports (week 10-11). After this two-week period, the number of sick reports decreased rapidly. The total number of sick reports in the first 20 weeks of 2020 is comparable or lower than the total number of sick reports in the same period in previous years.ConclusionWith this non-test-based strategy for employees combined with a restriction of visitors to the patients and strict isolation of COVID-19 (suspected) patients, there was no excessive absenteeism of work due to illness and there were only few patients with indications of COVID-19 acquisition in the hospital.
- 1 November 2019
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 25 (11) , 1428.e1-1428.e5
Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus in patients at hospital admission in The Netherlands, 2010–2017: an observational study
- 1 November 2019
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 25 (11) , 1428.e1-1428.e5
Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus in patients at hospital admission in The Netherlands, 2010–2017: an observational study